Ask what was tested in people
- Was the study in people?
- Did it use the same medicine and form?
- What health problem did it study?
- What did it measure?
- Does the proposed goal match that result?
A clear answer names the study and describes the result in ordinary words. Ask the doctor or other health professional to explain which parts apply to the proposed care.
Check what the source shows
Approval is specific to a product and use
The FDA (Food and Drug Administration) has granted approval for specific weight-loss uses of Wegovy (semaglutide), as of September 2026. This does not approve a whole package of peptide care. The FDA semaglutide label
Epitalon and MOTS-c are peptide names you may see in online offers. In September 2026, the FDA’s medicine-approval records had no approved US product for either. FDA application records
As of September 2026, having no approved product does not answer whether a pharmacy may make it to order or whether it is safe. Ask for answers to both questions before deciding.
Ask and note
What evidence shows a benefit for people with my health problem?
A government medicine record is not proof of approval
The FDA’s medicine directory gives each product an identifying number, the National Drug Code (NDC). As of September 2026, the FDA says that number does not prove the medicine is approved. FDA explains the drug-code directory
If someone shows you a medicine record or a product number on a government website, ask for the actual approval decision. A number in the directory is not that decision.
A report of a problem has limits
The FDA says reports of problems cannot establish how often they occur or prove that the medicine was their cause. FDA’s cautions about reported events
Ask what kind of source it is: a study in people, an official medicine approval or someone’s report of a problem. Ask what that source can and cannot answer.
Ask and note
Can you explain the source without turning uncertainty into a promise?